131 related articles for article (PubMed ID: 19708062)
21. Safety assessment of thiolated polymers: effect on ciliary beat frequency in human nasal epithelial cells.
Palmberger TF; Augustijns P; Vetter A; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2011 Dec; 37(12):1455-62. PubMed ID: 21635138
[TBL] [Abstract][Full Text] [Related]
22. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
[TBL] [Abstract][Full Text] [Related]
23. Development and application of an ex vivo fosphenytoin nasal bioconversion/permeability evaluation method.
Antunes Viegas D; Rodrigues M; Francisco J; Falcão A; Alves G; Santos AO
Eur J Pharm Sci; 2016 Jun; 89():61-72. PubMed ID: 27106504
[TBL] [Abstract][Full Text] [Related]
24. Insulin delivery through nasal route using thiolated microspheres.
Nema T; Jain A; Jain A; Shilpi S; Gulbake A; Hurkat P; Jain SK
Drug Deliv; 2013; 20(5):210-5. PubMed ID: 23495666
[TBL] [Abstract][Full Text] [Related]
25. Thiolated polymers: synthesis and in vitro evaluation of polymer-cysteamine conjugates.
Bernkop-Schnürch A; Clausen AE; Hnatyszyn M
Int J Pharm; 2001 Sep; 226(1-2):185-94. PubMed ID: 11532581
[TBL] [Abstract][Full Text] [Related]
26. Gastroretentive particles formulated with thiomers: development and in vitro evaluation.
Senyigit ZA; Vetter A; Guneri T; Bernkop-Schnürch A
J Drug Target; 2010 Jun; 18(5):362-72. PubMed ID: 20021230
[TBL] [Abstract][Full Text] [Related]
27. Evaluation and improvement of the properties of the novel cystine-knot microprotein McoEeTI for oral administration.
Werle M; Kafedjiiski K; Kolmar H; Bernkop-Schnürch A
Int J Pharm; 2007 Mar; 332(1-2):72-9. PubMed ID: 17070661
[TBL] [Abstract][Full Text] [Related]
28. Development of buccal drug delivery systems based on a thiolated polymer.
Langoth N; Kalbe J; Bernkop-Schnürch A
Int J Pharm; 2003 Feb; 252(1-2):141-8. PubMed ID: 12550789
[TBL] [Abstract][Full Text] [Related]
29. Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems.
Bernkop-Schnürch A; Kast CE; Guggi D
J Control Release; 2003 Dec; 93(2):95-103. PubMed ID: 14636716
[TBL] [Abstract][Full Text] [Related]
30. Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting.
Gavini E; Rassu G; Ferraro L; Beggiato S; Alhalaweh A; Velaga S; Marchetti N; Bandiera P; Giunchedi P; Dalpiaz A
Eur J Pharm Biopharm; 2013 Feb; 83(2):174-83. PubMed ID: 23153670
[TBL] [Abstract][Full Text] [Related]
31. Polycarbophil-cysteine conjugates as platforms for oral polypeptide delivery systems.
Bernkop-Schnürch A; Thaler SC
J Pharm Sci; 2000 Jul; 89(7):901-9. PubMed ID: 10861591
[TBL] [Abstract][Full Text] [Related]
32. In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: the enhancing effect of potassium sorbate.
Bortolotti F; Balducci AG; Sonvico F; Russo P; Colombo G
Eur J Pharm Sci; 2009 Apr; 37(1):36-42. PubMed ID: 19162181
[TBL] [Abstract][Full Text] [Related]
33. Mucoadhesive and cohesive properties of poly(acrylic acid)-cysteine conjugates with regard to their molecular mass.
Leitner VM; Marschütz MK; Bernkop-Schnürch A
Eur J Pharm Sci; 2003 Jan; 18(1):89-96. PubMed ID: 12554077
[TBL] [Abstract][Full Text] [Related]
34. In vivo evaluation of anionic thiolated polymers as oral delivery systems for efflux pump inhibition.
Palmberger TF; Laffleur F; Greindl M; Bernkop-Schnürch A
Int J Pharm; 2015 Aug; 491(1-2):318-22. PubMed ID: 26095915
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and characterisation of mucoadhesive thiolated polymers.
Bernkop-Schnürch A; Steininger S
Int J Pharm; 2000 Jan; 194(2):239-47. PubMed ID: 10692648
[TBL] [Abstract][Full Text] [Related]
36. Design and in vitro evaluation of a novel polymeric P-glycoprotein (P-gp) inhibitor.
Iqbal J; Hombach J; Matuszczak B; Bernkop-Schnürch A
J Control Release; 2010 Oct; 147(1):62-9. PubMed ID: 20603165
[TBL] [Abstract][Full Text] [Related]
37. Feasibility Investigation of Cellulose Polymers for Mucoadhesive Nasal Drug Delivery Applications.
Hansen K; Kim G; Desai KG; Patel H; Olsen KF; Curtis-Fisk J; Tocce E; Jordan S; Schwendeman SP
Mol Pharm; 2015 Aug; 12(8):2732-41. PubMed ID: 26097994
[TBL] [Abstract][Full Text] [Related]
38. Preparation of thiomer microparticles and in vitro evaluation of parameters influencing their mucoadhesive properties.
Albrecht K; Zirm EJ; Palmberger TF; Schlocker W; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2006; 32(10):1149-57. PubMed ID: 17090437
[TBL] [Abstract][Full Text] [Related]
39. Polymeric enhancers of mucosal epithelia permeability: synthesis, transepithelial penetration-enhancing properties, mechanism of action, safety issues.
Di Colo G; Zambito Y; Zaino C
J Pharm Sci; 2008 May; 97(5):1652-80. PubMed ID: 17828745
[TBL] [Abstract][Full Text] [Related]
40. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.
Khan A; Sommer W; Fuxe K; Akhtar S
J Drug Target; 2000; 8(5):319-34. PubMed ID: 11328659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
